ClinicalTrials.govpublic full text
Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
neuroendocrine tumors, net, somastostatin receptor, pet, dotatate, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807108
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.